Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : The Obama - Clinton Disaster -- Ignore unavailable to you. Want to Upgrade?

To: longnshort who wrote (13972)	6/20/2009 2:25:44 PM
From: pompsander	Read Replies (1) \| Respond to of 103300

Deal reached on cutting some U.S. drug costs: report WASHINGTON (Reuters) – Drug manufacturers have agreed to offer up to $80 billion in prescription drug discounts to government programs like Medicare, the Washington Post reported on Saturday, citing an unidentified source close to the talks. The board of the Pharmaceutical Research and Manufacturers of America on Friday approved the 10-year agreement which would affect those Medicare patients who have a gap in their prescription drug coverage, the newspaper reported. Medicare, the healthcare system for older and disabled Americans, has a gap in which some patients must pay full price for medicines after total costs reach a certain level, often referred to as the "doughnut hole". The proposed agreement would cut prices in half for the gap and also offer other discounts and rebates, giving President Barack Obama key savings as he pushes to overhaul the $2.5 trillion U.S. healthcare system, the Washington Post reported. Representatives for the industry association and a White House spokesman were not immediately available for comment. Addressing the costs of healthcare has been a top priority for Obama as they outpace inflation. Obama has also pledged to help the 46 million people without health insurance, but he faces a tough battle over just how to accomplish those goals.